| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium channel activity | 6.11e-04 | 129 | 6 | 2 | GO:0005262 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 8.35e-04 | 151 | 6 | 2 | GO:0015085 | |
| GeneOntologyMolecularFunction | gated channel activity | 4.00e-03 | 334 | 6 | 2 | GO:0022836 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 4.22e-03 | 343 | 6 | 2 | GO:0005261 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 7.44e-03 | 459 | 6 | 2 | GO:0005216 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 7.63e-03 | 465 | 6 | 2 | GO:0046873 | |
| GeneOntologyMolecularFunction | channel activity | 9.65e-03 | 525 | 6 | 2 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 9.68e-03 | 526 | 6 | 2 | GO:0022803 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 1.36e-02 | 627 | 6 | 2 | GO:0022890 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | 1.52e-02 | 664 | 6 | 2 | GO:0008324 | |
| GeneOntologyMolecularFunction | calcium ion binding | 1.91e-02 | 749 | 6 | 2 | GO:0005509 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | 1.95e-02 | 758 | 6 | 2 | GO:0015318 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | 2.12e-02 | 793 | 6 | 2 | GO:0015075 | |
| GeneOntologyBiologicalProcess | regulation of heart rate | 5.73e-04 | 129 | 6 | 2 | GO:0002027 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane import into cytosol | 1.61e-03 | 217 | 6 | 2 | GO:0097553 | |
| GeneOntologyBiologicalProcess | regulation of heart contraction | 2.11e-03 | 249 | 6 | 2 | GO:0008016 | |
| GeneOntologyBiologicalProcess | heart contraction | 3.00e-03 | 298 | 6 | 2 | GO:0060047 | |
| GeneOntologyBiologicalProcess | heart process | 3.22e-03 | 309 | 6 | 2 | GO:0003015 | |
| GeneOntologyBiologicalProcess | regulation of blood circulation | 3.58e-03 | 326 | 6 | 2 | GO:1903522 | |
| GeneOntologyBiologicalProcess | learning or memory | 4.66e-03 | 373 | 6 | 2 | GO:0007611 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport | 5.14e-03 | 392 | 6 | 2 | GO:0070588 | |
| GeneOntologyCellularComponent | calcium channel complex | 2.50e-04 | 73 | 7 | 2 | GO:0034704 | |
| MousePheno | abnormal mitochondrial morphology | 2.16e-03 | 209 | 5 | 2 | MP:0006035 | |
| Domain | Ion_trans_dom | 7.60e-04 | 114 | 7 | 2 | IPR005821 | |
| Domain | Ion_trans | 7.60e-04 | 114 | 7 | 2 | PF00520 | |
| Domain | EF_HAND_2 | 3.07e-03 | 231 | 7 | 2 | PS50222 | |
| Domain | EF_hand_dom | 3.10e-03 | 232 | 7 | 2 | IPR002048 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 1.16e-05 | 11 | 7 | 2 | M47958 | |
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 2.43e-05 | 38 | 7 | 2 | 30786075 | |
| GeneFamily | EF-hand domain containing | 2.95e-03 | 219 | 7 | 2 | 863 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#4_top-relative-expression-ranked_500 | 7.59e-05 | 41 | 7 | 2 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k4_500 | |
| ToppCell | LPS-antiTNF-Myeloid-Monocytes,_Macrophages-T-cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.89e-04 | 136 | 7 | 2 | 186be8e1595608004b8216892cb9c7a7f31fbb4d | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Fibroblasts-Pericyte_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.54e-04 | 158 | 7 | 2 | 7f5426585d0d299d2b48e5fcb349950feffdef33 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.61e-04 | 160 | 7 | 2 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.61e-04 | 160 | 7 | 2 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | 5'-Airway_Nasal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_acinar_cell-SMG_duct-SMG_duct_L.0.6.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.71e-04 | 163 | 7 | 2 | be6cc44df9a2b10dce1a353717c279c3558f8fec | |
| ToppCell | 5'-Airway_Nasal_SMG-Epithelial-Epithelial_transtional-secretory|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.71e-04 | 163 | 7 | 2 | f6847f47a8856c0d4136c1af317432d45eccfde9 | |
| ToppCell | 5'-Airway_Nasal_SMG|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.71e-04 | 163 | 7 | 2 | d8450bf9c6d2ec5dd1472952c9e65f82f995337a | |
| ToppCell | 5'-Airway_Nasal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_acinar_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.71e-04 | 163 | 7 | 2 | d9bd9d90cfa4e85d5ea51f8f3ee14a700571f508 | |
| ToppCell | 5'-Airway_Nasal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_acinar_cell-SMG_duct|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.71e-04 | 163 | 7 | 2 | a1fbefe53523a9879a4d4b493071059798b5f917 | |
| ToppCell | 5'-Airway_Nasal_SMG-Epithelial|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.71e-04 | 163 | 7 | 2 | 454a5e87e2f9f66e38cc5aa1b433c47b54c9be42 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-Tnaive/CM_CD4_activated|Liver / Manually curated celltypes from each tissue | 2.81e-04 | 166 | 7 | 2 | 9afa33b5ad27dc33576be592f9b22d8161366838 | |
| ToppCell | PBMC-Control-Hematopoietic-Platelet-Platelet-plt_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.88e-04 | 168 | 7 | 2 | 2f69e248c6fab1421c0081e01e1920e6ffcde344 | |
| ToppCell | PBMC-Control-Hematopoietic-Platelet-Platelet-plt_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.88e-04 | 168 | 7 | 2 | 2d056cfbb470a088a0682576753535fb4528d48f | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.08e-04 | 174 | 7 | 2 | 9f2e253694eb5860c00528fda31c305c6de8a2a1 | |
| ToppCell | 3'-Airway_Nasal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_mucus_secreting_cell-SMG_mucous-SMG_mucous_L.0.6.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.08e-04 | 174 | 7 | 2 | b1b54e4e23df8cfc04bf298d5c53de203a38b267 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Non-keratinizing_Cervical_Squamous_Cell_Carcinoma|TCGA-Cervix / Sample_Type by Project: Shred V9 | 3.15e-04 | 176 | 7 | 2 | 8513c2a05a34453a16bbcf1c11cb34c580133e47 | |
| ToppCell | (9)_Platelet|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 3.19e-04 | 177 | 7 | 2 | 0830944c43de300815831a9e2b2fce40965e7d12 | |
| ToppCell | (9)_Platelet|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 3.19e-04 | 177 | 7 | 2 | e63d01c7fce4fa1256212fa7e95f74281edb3a01 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-5|TCGA-Lung / Sample_Type by Project: Shred V9 | 3.19e-04 | 177 | 7 | 2 | a0c7d08469c513cecf87777c19876884f1511570 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Lymphocytic-CD45____B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.26e-04 | 179 | 7 | 2 | 69c74b2ff43b43653005807654953daf21f932ec | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Lymphocytic-B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.34e-04 | 181 | 7 | 2 | d90faa6115b408c9fbca61fc90ff951e070754ba | |
| ToppCell | Control-Epithelial-Basal|World / Disease state, Lineage and Cell class | 3.37e-04 | 182 | 7 | 2 | 759390dde9b18757f7675d13d44c89d0e32f8d93 | |
| ToppCell | Control-Epithelial-Basal|Control / Disease state, Lineage and Cell class | 3.37e-04 | 182 | 7 | 2 | caddd0a52f0234ea6a916186ffaf2454cdcd80ee | |
| ToppCell | COVID-19-Heart-CM_4|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.41e-04 | 183 | 7 | 2 | 2902b6e8aa9a6f62bc1a792c971ab7f651a8e676 | |
| ToppCell | 10x5'v1-week_17-19-Hematopoietic-MK-MK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.41e-04 | 183 | 7 | 2 | 9c66a40c355387f805dbdca4162dd05af5c1d8d4 | |
| ToppCell | 10x3'2.3-week_17-19-Hematopoietic-MK-MK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.45e-04 | 184 | 7 | 2 | ba65e3972b2b8d825a2c1a9d03d092cc1afad073 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.45e-04 | 184 | 7 | 2 | 25ccf08a8a26d7e7827b6357f33a53aaf423577d | |
| ToppCell | 3'-Airway_Nasal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_mucus_secreting_cell-SMG_mucous|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.48e-04 | 185 | 7 | 2 | b931ab35da10e6e3877071dce9b13fc0da63dc88 | |
| ToppCell | 3'-Airway_Nasal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_mucus_secreting_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.48e-04 | 185 | 7 | 2 | d9039770226338fbc3fce92aa229fad96e16db8c | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.52e-04 | 186 | 7 | 2 | 56c139e679d640ea901ead657a8e8887e0fca098 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.52e-04 | 186 | 7 | 2 | 7278a1a1bf9bb27aeb03852134defb31b62f30d6 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.56e-04 | 187 | 7 | 2 | 2f153b203fe79f206319603cf94d3a03ab49a05d | |
| ToppCell | 10x5'v1-week_17-19-Hematopoietic-MK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.56e-04 | 187 | 7 | 2 | 34cad5ac8602fe88ca3d421257190c9a388d4cb0 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.56e-04 | 187 | 7 | 2 | e04a84989d624378141042768383b9c846901f2d | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.56e-04 | 187 | 7 | 2 | 24cc03c748e15f7ef0e6509ca5a6ca583fb9c573 | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-bronchial_smooth_muscle_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.60e-04 | 188 | 7 | 2 | 7553ef7de3575af4cf34704b405b551c1af8eb83 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 3.60e-04 | 188 | 7 | 2 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-Airway_Smooth_Muscle|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.60e-04 | 188 | 7 | 2 | 61f010c165826b434ca3d27553d4c9e13d2c0c51 | |
| ToppCell | cellseq2-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-VEC|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.64e-04 | 189 | 7 | 2 | bccb3481ffed597c845fe860da658505316105b5 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma|TCGA-Lung / Sample_Type by Project: Shred V9 | 3.64e-04 | 189 | 7 | 2 | aa4f7d7a5196e5ae481ebc2549de8e3f0ef6e6be | |
| ToppCell | IPF-Epithelial-Basal|IPF / Disease state, Lineage and Cell class | 3.67e-04 | 190 | 7 | 2 | ea19e9ce954f2dfde97388db9695325cd92ab88f | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 3.71e-04 | 191 | 7 | 2 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | 10x5'v1-week_14-16-Hematopoietic-MK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.71e-04 | 191 | 7 | 2 | 7edc22e7e70697fb22690699efb352577162709b | |
| ToppCell | 10x5'v1-week_14-16-Hematopoietic-MK-MK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.75e-04 | 192 | 7 | 2 | b877d14be9d04ab0010e340909e3a23de92613db | |
| ToppCell | IPF-Epithelial-Basal|World / Disease state, Lineage and Cell class | 3.75e-04 | 192 | 7 | 2 | 9b91e0b162e6f3ce86dd15cc33c2e745d069581f | |
| ToppCell | COPD-Lymphoid-T|World / Disease state, Lineage and Cell class | 3.75e-04 | 192 | 7 | 2 | eb4909574fb5fc91399463523e2737095773200a | |
| ToppCell | Megakaryocytic-erythropoietic-Megakaryo-cells-Megakaryocyte|World / Lineage, cell class and subclass | 3.79e-04 | 193 | 7 | 2 | 352cd442b6e62f09b6d22a139774067873644594 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.79e-04 | 193 | 7 | 2 | 0c652ebe22ce5d2927599dd97ef1920547858395 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.79e-04 | 193 | 7 | 2 | 8689a70a33a7c3823dc647d41ac0160e7c3ae396 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.79e-04 | 193 | 7 | 2 | be28070c049e7cb68bcd54f582226eb2f5e4bc1c | |
| ToppCell | LA-05._Cytoplasmic_Cardiomyocyte_I|LA / Chamber and Cluster_Paper | 3.83e-04 | 194 | 7 | 2 | e4b3a896e79666a935171af05c8d0b68de4fee32 | |
| ToppCell | 10x3'2.3-week_14-16-Hematopoietic-MK-MK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.91e-04 | 196 | 7 | 2 | 66ba31b74953726e9c314f6d8fe3f75d3762e23a | |
| ToppCell | COPD-Lymphoid-T|COPD / Disease state, Lineage and Cell class | 3.91e-04 | 196 | 7 | 2 | 30e53b8050d2a041f855d0e39bbd8f923c64c489 | |
| ToppCell | cellseq-Epithelial-Epithelial_Airway|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.91e-04 | 196 | 7 | 2 | faa39c567f24403e511b240c1d1a654ffadd8473 | |
| ToppCell | Bronchus_Control_(B.)|World / Sample group, Lineage and Cell type | 3.95e-04 | 197 | 7 | 2 | b6dff2ee108813e18657e2d8cf850e2423f8c8e9 | |
| ToppCell | 3'-Broncho-tracheal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.95e-04 | 197 | 7 | 2 | 5d33f8a6940431093e927b186fb9b630a89d8ec1 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.95e-04 | 197 | 7 | 2 | fb272c9c60ee3d980e528044dc567b4925a23da6 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.95e-04 | 197 | 7 | 2 | 1d4ccca2ff46fccb3ac052b5148cb7f94231d65a | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.95e-04 | 197 | 7 | 2 | 61c0d78b29dc4ad8a84172cbfcdab03f31351d0e | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.95e-04 | 197 | 7 | 2 | 233b9fcb376e08d0080a05ca0198ecc6ec720f90 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.99e-04 | 198 | 7 | 2 | aa6e7218ee6230902854e66c444b544218b30c0e | |
| ToppCell | Control-PLT_4|Control / Disease Group and Platelet Clusters | 3.99e-04 | 198 | 7 | 2 | 387fd3037fd52e4d4c42de0588767e58af228b59 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.99e-04 | 198 | 7 | 2 | fc00cb25cdc6c31b7f9d397bc9f9a8f4e9708003 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.99e-04 | 198 | 7 | 2 | 22935a8afac54021f68b5f7a5accf51523e2f336 | |
| ToppCell | cellseq-Epithelial-Epithelial_Airway-Basal/Suprabasal-Suprabasal|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.99e-04 | 198 | 7 | 2 | 6e047de63ef59dcb47e4fc06b173b2a02fdcf4c9 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.99e-04 | 198 | 7 | 2 | 89ec1e760a193441092571475cc66a3b425f232e | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.4|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.99e-04 | 198 | 7 | 2 | 77517df37dc894c78ef1e2b24dd7ba31f928bdb7 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Suprabasal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.99e-04 | 198 | 7 | 2 | 19d8ff3a4f911b13ecc34844202925475ad4d2ab | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_basal-Suprabasal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.03e-04 | 199 | 7 | 2 | f5c3561744e2a0e7716657cb521acb1d8f054b41 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G-|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.03e-04 | 199 | 7 | 2 | 9c6d1c328bfbb6547f4c7bb2a784576a56bd72af | |
| ToppCell | cellseq-Epithelial-Epithelial_Airway-Basal/Suprabasal|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.03e-04 | 199 | 7 | 2 | 974f71b56f66243c78f2f297a1540e0e186df530 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.03e-04 | 199 | 7 | 2 | c88a28a73f54dc571f2ff1e4b55073f83cbead2c | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.03e-04 | 199 | 7 | 2 | f4b6c095cbe7a38b310adc49be4069e4d56e6a66 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_basal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.07e-04 | 200 | 7 | 2 | afac850d5a40de0d6f02857cf81a19443d90b1eb | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer|World / Primary Cells by Cluster | 4.07e-04 | 200 | 7 | 2 | db10f76938af553d1a2275bb02ef75dff3c3135b | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.07e-04 | 200 | 7 | 2 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_basal-Suprabasal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.07e-04 | 200 | 7 | 2 | ce969c958a31145bbfe315a9a865d7900ecc9549 | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.07e-04 | 200 | 7 | 2 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.07e-04 | 200 | 7 | 2 | 85c0f038bcfb42669dca2b80273b0f8a1421405e | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer-21|World / Primary Cells by Cluster | 4.07e-04 | 200 | 7 | 2 | 30a3e4aee12ec1b5acdce90f86c9733c27a7f6fc | |
| Drug | nisoldipine | 1.34e-06 | 78 | 7 | 3 | CID000004499 | |
| Drug | nicardipine | 8.69e-06 | 145 | 7 | 3 | CID000004473 | |
| Drug | papaverine | 1.55e-05 | 176 | 7 | 3 | CID000004680 | |
| Drug | IHC-64 | 4.26e-05 | 33 | 7 | 2 | CID000162753 | |
| Drug | CNS 1145 | 4.26e-05 | 33 | 7 | 2 | CID000190902 | |
| Drug | Cinildipine | 1.24e-04 | 56 | 7 | 2 | CID000002752 | |
| Drug | nilvadipine | 1.42e-04 | 60 | 7 | 2 | CID000004494 | |
| Drug | IAA-94 | 1.47e-04 | 61 | 7 | 2 | CID000003667 | |
| Drug | lercanidipine | 1.57e-04 | 63 | 7 | 2 | CID000065866 | |
| Drug | gallopamil | 1.77e-04 | 67 | 7 | 2 | CID000001234 | |
| Drug | AC1L2AC7 | 1.88e-04 | 69 | 7 | 2 | CID000068733 | |
| Drug | CAS 298-57-7 | 2.11e-04 | 73 | 7 | 2 | CID000002761 | |
| Drug | ethosuximide | 2.17e-04 | 74 | 7 | 2 | CID000003291 | |
| Drug | N-cyclopentyl-N-cyclobutylformamide | 2.47e-04 | 79 | 7 | 2 | CID005287890 | |
| Drug | XeC compound | 2.79e-04 | 84 | 7 | 2 | CID000005701 | |
| Drug | guaifenesin | 2.99e-04 | 87 | 7 | 2 | CID000003516 | |
| Drug | phosphopantotheine | 3.06e-04 | 88 | 7 | 2 | CID000000987 | |
| Drug | manidipine | 3.57e-04 | 95 | 7 | 2 | CID000004008 | |
| Drug | adenine | 3.66e-04 | 510 | 7 | 3 | CID000000190 | |
| Drug | isotetrandrine | 3.72e-04 | 97 | 7 | 2 | CID000005422 | |
| Drug | nitrendipine | 3.80e-04 | 98 | 7 | 2 | CID000004507 | |
| Drug | isradipine | 3.95e-04 | 100 | 7 | 2 | CID000003784 | |
| Drug | loperamide | 4.36e-04 | 105 | 7 | 2 | CID000003954 | |
| Drug | guanosine 3',5'-cyclic monophosphoric acid | 5.25e-04 | 577 | 7 | 3 | CID000000295 | |
| Drug | lamotrigine | 5.31e-04 | 116 | 7 | 2 | CID000003878 | |
| Drug | AC1NBU2S | 5.41e-04 | 117 | 7 | 2 | CID004473765 | |
| Drug | bepridil | 6.27e-04 | 126 | 7 | 2 | CID000002351 | |
| Drug | pimozide | 6.37e-04 | 127 | 7 | 2 | CID000016362 | |
| Drug | lanthanum | 7.29e-04 | 136 | 7 | 2 | CID000023926 | |
| Drug | zaprinast | 7.84e-04 | 141 | 7 | 2 | CID000005722 | |
| Drug | Dantrolene-13C3 | 8.28e-04 | 145 | 7 | 2 | CID000002951 | |
| Drug | nimodipine | 8.28e-04 | 145 | 7 | 2 | CID000004497 | |
| Drug | selenite | 8.63e-04 | 148 | 7 | 2 | CID000001090 | |
| Drug | Bay K 8644 | 8.86e-04 | 150 | 7 | 2 | CID000002303 | |
| Drug | procaine | 9.22e-04 | 153 | 7 | 2 | CID000004914 | |
| Drug | lindane | 9.34e-04 | 154 | 7 | 2 | CID000000727 | |
| Drug | gabapentin | 1.12e-03 | 169 | 7 | 2 | CID000003446 | |
| Drug | felodipine | 1.12e-03 | 169 | 7 | 2 | CID000003333 | |
| Drug | lavendustin A | 1.15e-03 | 171 | 7 | 2 | CID000003894 | |
| Drug | arabinosyladenine | 1.18e-03 | 762 | 7 | 3 | CID000000191 | |
| Drug | riluzole | 1.19e-03 | 174 | 7 | 2 | CID000005070 | |
| Drug | NSC7524 | 1.30e-03 | 182 | 7 | 2 | CID000005657 | |
| Drug | manganese | 1.32e-03 | 791 | 7 | 3 | CID000023930 | |
| Drug | foscarnet | 1.42e-03 | 190 | 7 | 2 | CID000003414 | |
| Drug | NSC759576 | 1.43e-03 | 191 | 7 | 2 | CID000003075 | |
| Drug | baclofen | 1.43e-03 | 191 | 7 | 2 | CID000002284 | |
| Drug | dihydropyridine | 1.46e-03 | 193 | 7 | 2 | CID000104822 | |
| Drug | Methantheline bromide [53-46-3]; Down 200; 9.6uM; PC3; HT_HG-U133A | 1.52e-03 | 197 | 7 | 2 | 5780_DN | |
| Drug | Quinic acid [86-68-0]; Up 200; 19.6uM; MCF7; HT_HG-U133A | 1.54e-03 | 198 | 7 | 2 | 6019_UP | |
| Drug | C070379 | 1.55e-03 | 199 | 7 | 2 | CID003034747 | |
| Drug | Azlocillin sodium salt [37091-65-9]; Down 200; 8.2uM; PC3; HT_HG-U133A | 1.55e-03 | 199 | 7 | 2 | 5788_DN | |
| Drug | gadolinium | 1.55e-03 | 199 | 7 | 2 | CID000023982 | |
| Disease | Seizures | 7.99e-04 | 218 | 6 | 2 | C0036572 | |
| Disease | cognitive function measurement, self reported educational attainment | 2.10e-03 | 355 | 6 | 2 | EFO_0004784, EFO_0008354 | |
| Disease | serum IgG glycosylation measurement | 4.49e-03 | 523 | 6 | 2 | EFO_0005193 | |
| Disease | urate measurement, bone density | 6.23e-03 | 619 | 6 | 2 | EFO_0003923, EFO_0004531 | |
| Disease | risk-taking behaviour | 9.37e-03 | 764 | 6 | 2 | EFO_0008579 | |
| Disease | unipolar depression | 2.24e-02 | 1206 | 6 | 2 | EFO_0003761 | |
| Disease | cognitive function measurement | 3.11e-02 | 1434 | 6 | 2 | EFO_0008354 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YTEMYEMLTLMSPPL | 1761 | Q15878 | |
| YMLPSSYHTPEKDMM | 291 | Q8NH00 | |
| EMVYPSESTVMPNMY | 1061 | P23471 | |
| MSPVFPMLTVLTMFY | 1 | Q9UKA2 | |
| MSPALVYPFMRSVME | 616 | Q68D51 | |
| LPPDYMESNYVSMME | 2676 | Q92736 | |
| SPSEYLMMLMPPSQE | 241 | Q9NVU0 | |
| TRTPYTASLMRMPYM | 481 | A8MUU9 |